Appointment of Chief Executive Officer – Dr Anne Brindley to start with immediate effect

7th December 2020

Cambridge, UK – 7 December 2020: Nuformix plc (LSE:NFX; “Nuformix”, the “Company” or the “Group”), a drug re-purposing specialist, is pleased to announce the appointment of Dr Anne Brindley as Chief Executive Officer “CEO” and Executive Director of the Company with immediate effect. Download News

Back to all News